Kura Oncology (KURA) Reports In-Line Q3 EPS

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.63), in-line with the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg
• Village Super Market (VLGEA) Declares $0.25 Quarterly Dividend; 2.4% Yield
• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'